Navigating the human gastrointestinal tract for oral drug delivery: Uncharted waters and new frontiers.
暂无分享,去创建一个
Michael Grimm | Jens-Peter Kühn | Werner Weitschies | Mirko Koziolek | Werner Siegmund | J. Kühn | M. Grimm | W. Weitschies | M. Koziolek | Felix Schneider | F. Schneider | Philipp Jedamzik | Maximilian Sager | W. Siegmund | Maximilian Sager | Philipp Jedamzik | Felix Schneider
[1] Werner Weitschies,et al. An Automated System for Monitoring and Regulating the pH of Bicarbonate Buffers , 2013, AAPS PharmSciTech.
[2] Martin Bergstrand,et al. PBPK models for the prediction of in vivo performance of oral dosage forms. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[3] W. Weitschies,et al. Development of pressure-sensitive dosage forms with a core liquefying at body temperature. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[4] I. Wilding,et al. The in vivo behaviour of enteric naproxen tablets coated with an aqueous dispersion of methacrylic acid copolymer , 1997 .
[5] B. Meibohm,et al. Pharmacokinetics of immunosuppressants: a perspective on ethnic differences. , 2004, International journal of clinical pharmacology and therapeutics.
[6] R. Havenaar,et al. A computer-controlled system to simulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation products , 1999, Applied Microbiology and Biotechnology.
[7] I. Wilding,et al. The effect of food on the in vivo behaviour of enteric coated starch capsules , 1994 .
[8] A. Gasbarrini,et al. Levothyroxine absorption in health and disease, and new therapeutic perspectives. , 2014, European review for medical and pharmacological sciences.
[9] Ayman El-Kattan,et al. Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans. , 2007, Expert opinion on drug metabolism & toxicology.
[10] K. Schulze. Imaging and modelling of digestion in the stomach and the duodenum , 2006, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[11] M. Horowitz,et al. Gastric emptying in normal subjects--a reproducible technique using a single scintillation camera and computer system. , 1983, Gut.
[12] M. Wickham,et al. Predicting the human in vivo performance of different oral capsule shell types using a novel in vitro dynamic gastric model. , 2011, International journal of pharmaceutics.
[13] E. Bjornsson,et al. Nocturnal Antral pH Rises Are Related to Duodenal Phase III Retroperistalsis , 1997, Digestive Diseases and Sciences.
[14] G. Boeckxstaens,et al. The Acid Pocket: A Target for Treatment in Reflux Disease? , 2013, The American Journal of Gastroenterology.
[15] J. H. Baron,et al. Long-term recording and computer analysis of simultaneous gastric and duodenal pH under normal conditions in man , 1980 .
[16] M. Karsdal,et al. Influence of food intake on the bioavailability and efficacy of oral calcitonin. , 2009, British Journal of Clinical Pharmacology.
[17] C. Lipinski. Lead- and drug-like compounds: the rule-of-five revolution. , 2004, Drug discovery today. Technologies.
[18] M. Grimm,et al. Intragastric pH and pressure profiles after intake of the high-caloric, high-fat meal as used for food effect studies. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[19] Characterization of the behavior of alginate-based microcapsules in vitro and in vivo. , 2009, International journal of clinical pharmacology and therapeutics.
[20] A. Zinsmeister,et al. Human gastric emptying and colonic filling of solids characterized by a new method. , 1989, The American journal of physiology.
[21] M. Karsdal,et al. Optimizing bioavailability of oral administration of small peptides through pharmacokinetic and pharmacodynamic parameters: The effect of water and timing of meal intake on oral delivery of Salmon Calcitonin , 2008, BMC clinical pharmacology.
[22] W. Weitschies,et al. A dynamic system for the simulation of fasting luminal pH-gradients using hydrogen carbonate buffers for dissolution testing of ionisable compounds. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[23] P. Boesiger,et al. Quantification of distal antral contractile motility in healthy human stomach with magnetic resonance imaging , 2006, Journal of magnetic resonance imaging : JMRI.
[24] J. Proost,et al. Sex Differences in the Pharmacokinetics of Antidepressants: Influence of Female Sex Hormones and Oral Contraceptives , 2014, Clinical Pharmacokinetics.
[25] V. Bhargava,et al. Effect of proton pump inhibition on the gastric volume: assessed by magnetic resonance imaging , 2009, Alimentary pharmacology & therapeutics.
[26] C. Christiansen,et al. Lessons Learned From the Development of Oral Calcitonin: The First Tablet Formulation of a Protein in Phase III Clinical Trials , 2011, Journal of clinical pharmacology.
[27] N. Hosten,et al. Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging , 2005, Alimentary pharmacology & therapeutics.
[28] Clive G. Wilson,et al. In vivo imaging of drug delivery systems in the gastrointestinal tract. , 2011, International journal of pharmaceutics.
[29] H. Lennernäs,et al. Characterization of Fluids from the Stomach and Proximal Jejunum in Men and Women , 1997, Pharmaceutical Research.
[30] Mark McAllister,et al. Dynamic dissolution: a step closer to predictive dissolution testing? , 2010, Molecular pharmaceutics.
[31] I. Wilding,et al. The evaluation of an enteric-coated naproxen tablet formulation using gamma scintigraphy , 1993 .
[32] Lutz Trahms,et al. Impact of the intragastric location of extended release tablets on food interactions. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[33] C. I. Baastrup. Roentgenological Studies of the Inner Surface of the Stomach and of the Movements of the Gastic Contents , 1924 .
[34] C. Barthélémy,et al. Contribution of scintigraphy to verify the reliability of different preparation processes for enteric coated capsules , 1994, European Journal of Drug Metabolism and Pharmacokinetics.
[35] D. Fleisher,et al. Drug, Meal and Formulation Interactions Influencing Drug Absorption After Oral Administration , 1999, Clinical pharmacokinetics.
[36] L. Fändriks,et al. Human duodenogastric reflux, retroperistalsis, and MMC. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.
[37] Y F Shiau,et al. Mechanisms maintaining a low-pH microclimate in the intestine. , 1985, The American journal of physiology.
[38] M. Camilleri,et al. Consensus Recommendations for Gastric Emptying Scintigraphy: A Joint Report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine , 2008, The American Journal of Gastroenterology.
[39] B. Bittner,et al. Oral Delivery of Therapeutic Proteins and Peptides: An Overview of Current Technologies and Recommendations for Bridging from Approved Intravenous or Subcutaneous Administration to Novel Oral Regimens , 2015, Drug Research.
[40] M. Ratain,et al. Inconsistent Labeling of Food Effect for Oral Agents across Therapeutic Areas: Differences between Oncology and Non-Oncology Products , 2010, Clinical Cancer Research.
[41] Jan Tack,et al. The migrating motor complex: control mechanisms and its role in health and disease , 2012, Nature Reviews Gastroenterology &Hepatology.
[42] C L Hoad,et al. Fasting and postprandial volumes of the undisturbed colon: normal values and changes in diarrhea-predominant irritable bowel syndrome measured using serial MRI , 2013, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[43] M. Türe,et al. The Effect of Intravenous Pantoprazole and Ranitidine for Improving Preoperative Gastric Fluid Properties in Adults Undergoing Elective Surgery , 2003, Anesthesia and analgesia.
[44] Clive G. Wilson,et al. Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[45] Monitoring the Intragastric Distribution of a Colloidal Drug Carrier Model by Magnetic Resonance Imaging , 2001, Pharmaceutical Research.
[46] R. Löbenberg,et al. Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs , 1998, Pharmaceutical Research.
[47] A. Basit,et al. Gut instincts: explorations in intestinal physiology and drug delivery. , 2008, International journal of pharmaceutics.
[48] L. Trahms,et al. Magnetic marker monitoring of esophageal, gastric and duodenal transit of non-disintegrating capsules. , 1999, Die Pharmazie.
[49] W. Weitschies,et al. Bio-relevant dissolution testing of hard capsules prepared from different shell materials using the dynamic open flow through test apparatus. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[50] I. Wilding,et al. In Vivo Evaluation of Enteric-Coated Naproxen Tablets Using Gamma Scintigraphy , 1992, Pharmaceutical Research.
[51] Migrating motor complex cycle duration is determined by gastric or duodenal origin of phase III. , 1998, American journal of physiology. Gastrointestinal and liver physiology.
[52] L. Marciani,et al. Effect of meal viscosity and nutrients on satiety, intragastric dilution, and emptying assessed by MRI. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[53] Jeffrey W. Scott,et al. Effects of meal type on the oral bioavailability of the ALK inhibitor ceritinib in healthy adult subjects , 2016, Journal of clinical pharmacology.
[54] W. Weitschies,et al. Development of a pressure-sensitive glyceryl tristearate capsule filled with a drug-containing hydrogel. , 2014, International journal of pharmaceutics.
[55] Martin C Garnett,et al. Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state. , 2014, Molecular pharmaceutics.
[56] Christel A. S. Bergström,et al. Is the full potential of the biopharmaceutics classification system reached? , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[57] R. Singh,et al. Disintegration of solid foods in human stomach. , 2008, Journal of food science.
[58] R. Havenaar,et al. Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of bile. , 1997, Journal of dairy science.
[59] J. Maltby,et al. Fasting from midnight--the history behind the dogma. , 2006, Best practice & research. Clinical anaesthesiology.
[60] J. Kühn,et al. Intragastric volume changes after intake of a high-caloric, high-fat standard breakfast in healthy human subjects investigated by MRI. , 2014, Molecular pharmaceutics.
[61] J. Malagelada,et al. Different gastric, pancreatic, and biliary responses to solid-liquid or homogenized meals , 1979, Digestive Diseases and Sciences.
[62] R. Fisher,et al. Gastric emptying of a non‐digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy , 2008, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[63] J Michael Newton,et al. Gastric emptying of multi-particulate dosage forms. , 2010, International journal of pharmaceutics.
[64] L. Fändriks,et al. Surface area of the digestive tract – revisited , 2014, Scandinavian journal of gastroenterology.
[65] Abdul W Basit,et al. Animal Farm: Considerations in Animal Gastrointestinal Physiology and Relevance to Drug Delivery in Humans. , 2015, Journal of pharmaceutical sciences.
[66] Anette Müllertz,et al. In vitro models for the prediction of in vivo performance of oral dosage forms. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[67] C. Porter,et al. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs , 2007, Nature Reviews Drug Discovery.
[68] S. Davis,et al. Alimentary tract andpancreas Transit ofpharmaceutical dosage forms through the , 1986 .
[69] John J Totman,et al. Postprandial changes in small bowel water content in healthy subjects and patients with irritable bowel syndrome. , 2010, Gastroenterology.
[70] Christos Reppas,et al. In-vitro simulation of luminal conditions for evaluation of performance of oral drug products: Choosing the appropriate test media. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[71] J. Madsen,et al. Human migrating myoelectric complex in relation to gastrointestinal transit of a meal. , 1990, Gut.
[72] A. Shafik,et al. Physiological assessment of the function of the ileocecal junction with evidence of ileocecal junction reflexes. , 2002, Medical science monitor : international medical journal of experimental and clinical research.
[73] H. Mönnikes,et al. Magnetic marker monitoring: high resolution real-time tracking of oral solid dosage forms in the gastrointestinal tract. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[74] Sang Chung,et al. New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process , 2008, Journal of clinical pharmacology.
[75] M. Yasin,et al. An Investigation into the Utility of a Multi-compartmental, Dynamic, System of the Upper Gastrointestinal Tract to Support Formulation Development and Establish Bioequivalence of Poorly Soluble Drugs , 2012, The AAPS Journal.
[76] Sebastian Polak,et al. Population-Based Mechanistic Prediction of Oral Drug Absorption , 2009, The AAPS Journal.
[77] Bertil Abrahamsson,et al. Comparison of dissolution profiles obtained from nifedipine extended release once a day products using different dissolution test apparatuses. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[78] P. Boesiger,et al. The effect of macronutrients on gastric volume responses and gastric emptying in humans: A magnetic resonance imaging study. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[79] J. Malagelada. Quantificantion of gastric solid-liquid discrimination during digestion of ordinary meals. , 1977, Gastroenterology.
[80] W. Weitschies. Oral Anticancer Drugs: Back to Square One , 2013, Clinical pharmacology and therapeutics.
[81] M. Grimm,et al. Investigation of pH and Temperature Profiles in the GI Tract of Fasted Human Subjects Using the Intellicap(®) System. , 2015, Journal of pharmaceutical sciences.
[82] J. P. Ebel,et al. An in Vitro/in Vivo Correlation for the Disintegration and Onset of Drug Release from Enteric-Coated Pellets , 1993, Pharmaceutical Research.
[83] P. Boesiger,et al. The effect of gastric secretion on gastric physiology and emptying in the fasted and fed state assessed by magnetic resonance imaging , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[84] Frédéric Carrière,et al. Impact of gastrointestinal lipolysis on oral lipid-based formulations and bioavailability of lipophilic drugs. , 2016, Biochimie.
[85] E. Brendel,et al. Formulation-dependent food effects demonstrated for nifedipine modified-release preparations marketed in the European Union. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[86] M. Camilleri. Integrated upper gastrointestinal response to food intake. , 2006, Gastroenterology.
[87] R. Spiller,et al. Emptying of the terminal ileum in intact humans: Influence of meal residue and ileal motility , 1987 .
[88] L. Trahms,et al. Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[89] J. H. Baron,et al. Duodenal pH in health and duodenal ulcer disease: effect of a meal, Coca-Cola, smoking, and cimetidine. , 1984, Gut.
[90] Lutz Trahms,et al. Magnetic Marker Monitoring: An application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms. , 2005, Advanced drug delivery reviews.
[91] I. Wilding,et al. Correlation of the Gastric Emptying of Nondisintegrating Tablets with Gastrointestinal Motility , 1991, Pharmaceutical Research.
[92] F. Podczeck,et al. The influence of non‐disintegrating tablet dimensions and density on their gastric emptying in fasted volunteers , 2007, The Journal of pharmacy and pharmacology.
[93] W. Weitschies,et al. A biorelevant dissolution stress test device – background and experiences , 2010, Expert opinion on drug delivery.
[94] Mark McAllister,et al. Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[95] G. Dresser,et al. Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: Comparison with grapefruit juice , 2003, Clinical pharmacology and therapeutics.
[96] W. Weitschies,et al. Simulating the postprandial stomach: physiological considerations for dissolution and release testing. , 2013, Molecular pharmaceutics.
[97] G. Jefferson. The Human Stomach and the Canalis Gastricus (Lewis). , 1915, Journal of anatomy and physiology.
[98] C. Dooley,et al. Variability of migrating motor complex in humans , 1992, Digestive Diseases and Sciences.
[99] J. Seenan,et al. Paradox of gastric cardia: it becomes more acidic following meals while the rest of stomach becomes less acidic , 2008, Gut.
[100] I. Wilding,et al. Enteric coated HPMC capsules designed to achieve intestinal targeting. , 2002, International journal of pharmaceutics.
[101] A. Basit,et al. Dissolution of pH responsive formulations in media resembling intestinal fluids: bicarbonate versus phosphate buffers , 2005 .
[102] J. Tack,et al. Gastrointestinal Behavior of Weakly Acidic BCS Class II Drugs in Man--Case Study of Diclofenac Potassium. , 2016, Journal of pharmaceutical sciences.
[103] M. Karlsson,et al. Meta-analysis of Magnetic Marker Monitoring Data to Characterize the Movement of Single Unit Dosage Forms Though the Gastrointestinal Tract Under Fed and Fasting Conditions , 2016, Pharmaceutical Research.
[104] Gordon L Amidon,et al. Toward an in vivo dissolution methodology: a comparison of phosphate and bicarbonate buffers. , 2009, Molecular pharmaceutics.
[105] Susan A. Barker,et al. Achieving Antral Grinding Forces in Biorelevant In Vitro Models: Comparing the USP Dissolution Apparatus II and the Dynamic Gastric Model with Human In Vivo Data , 2011, AAPS PharmSciTech.
[106] M. Alpsten,et al. Absorption of acetylsalicylic acid from enteric‐coated tablets in relation to gastric emptying and in‐vivo disintegration , 1984, The Journal of pharmacy and pharmacology.
[107] W. Weitschies,et al. Simulating the postprandial stomach: biorelevant test methods for the estimation of intragastric drug dissolution. , 2013, Molecular pharmaceutics.
[108] Mark Feldman,et al. Fasting gastric pH and its relationship to true hypochlorhydria in humans , 1991, Digestive Diseases and Sciences.
[109] Clive G. Wilson,et al. Gastrointestinal Transit and Drug Absorption , 2005 .
[110] G. Boeckxstaens,et al. The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD , 2009, Gut.
[111] A. Basit,et al. Oral modified-release formulations in motion: the relationship between gastrointestinal transit and drug absorption. , 2010, International journal of pharmaceutics.
[112] Werner Weitschies,et al. Development of a bio-relevant dissolution test device simulating mechanical aspects present in the fed stomach. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.